治疗耐药抑郁症的新兴药物:对机制和挑战的视角进行审查
Michael J Lucido1, Boadie W Dunlop1
1Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
Brain sciences
|February 26, 2025
概括
针对谷氨酸和迷幻药物的研究药物显示出对治疗耐药抑郁症 (TRD) 的承诺. 研究正在探索新的机制,以解决这个具有挑战性的条件和相关的症状,如无情和自杀.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 临床精神病学 临床精神病学
- 药物开发 药物开发
背景情况:
- 大型抑郁症 (MDD) 没有反应是一个重要的临床问题.
- 对于治疗耐药性抑郁症 (TRD) 存在有限的批准治疗方法.
- 需要针对TRD和相关症状制定新的治疗策略.
研究的目的:
- 识别和分类正在进行的TRD临床试验.
- 检查针对TRD,无情和自杀倾向的试验药物.
- 了解新型TRD治疗的作用机制.
主要方法:
- 美国和欧盟临床试验注册表的系统搜索 (2020年1月1日以后).
- 搜索了"耐治疗抑郁症"",抑郁症" (反应不足),"自杀"和"无情感".
- 根据实验药物的主要作用机制对试验进行了分类.
主要成果:
- 确定了50个TRD,20个无,和25个自杀临床试验.
- 谷氨酸系统调制 (NMDA,AMPA受体) 是一个主要的开发领域.
- 迷幻药物,特别是 псилоцибин,显示越来越多的研究兴趣;其他机制包括GABA,单胺,抗炎和素对手.
结论:
- 试验药物为更有效和个性化的TRD治疗提供了潜力.
- 在TRD疗效检测方面的挑战包括患者异质性和并发症.
- 需要进一步的研究,以克服开发TRD治疗方法的挑战.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...